Perseon Corporation
PRSN
NASDAQ0.07
USD
-0.02
- -
CIK
0000320174
ISIN
US7152702038
Return %
Stock
S&P500
1Y
- -
26.84
3Y
- -
77.03
5Y
- -
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 2188 West 2200 South Salt Lake City United States of America 84119
- IPO Date
- Jun 23, 2005
- CIK
- 0000320174
- Website
- perseonmedical.com
- Similar Companies
- Business
- Perseon Corporation (PRSN) develops, manufactures, markets and services medical systems that treat cancer using heat therapies, including hyperthermia systems for oncology applications such as the Sigma family of hyperthermia systems and the MicroThermX microwave generators; it offers electro-medical and electrotherapeutic apparatus focused on non-invasive cancer treatment solutions. The company, formerly known as BSD Medical Corporation, was incorporated in Delaware in 1986, changed its name to Perseon Corporation around 2016, and maintains headquarters in Salt Lake City, Utah, with operations primarily in the United States targeting healthcare providers and oncology centers worldwide. In recent developments, Perseon has continued to emphasize its legacy hyperthermia technology platform amid a dormant profile in public markets, with no major funding rounds, acquisitions, partnerships or new product launches reported in the last 1-2 years as of late 2025.